You searched for Antibody candidate - Page 43 of 69

Best in Biotech 29 Mar 2023

5 hearing loss biotech companies you should know about

…pathophysiology and etiology of diseases related to hearing loss, allowing it to select the best targets and mechanisms of action for drug candidates. SENS-401 is Sensorion’s clinical-stage small molecule drug…

March 29, 2023 - 7 minutesmins - By Willow Shah-Neville

In Depth 1 Nov 2024

Can AI cure Alzheimer’s disease?

…AI platform, Centaur Chemist, uses predictive modeling to streamline the selection of candidate compounds. This platform has already brought three AI-designed drug candidates to clinical testing, including DSP-0038 for Alzheimer’s…

November 1, 2024 - 9 minutesmins - By Jules Adam

In Depth 20 Nov 2024

Hypoparathyroidism: rare endocrine disorder garners attention from biopharma in 2024

…alike. U.S.-based MBX’s $187.7 million offering will fund its lead candidate MBX 2109 – hoping to take on Yorvipath – into phase 3 studies. The IPO was following the news…

November 20, 2024 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 10 May 2023

5 cell therapy companies you should know about

…pipeline includes candidates being investigated for the treatment of synovial sarcoma, head and neck cancer, esophageal cancer, ovarian cancer, and more. Afamitresgene autocel is the company’s first-generation TCR T-cell therapy…

May 10, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 3 Feb 2023

Genoscience Pharma receives orphan drug designation for hepatocellular carcinoma drug

Genoscience Pharma has announced that its lead candidate, ezurpimtrostat, a PPT-1 (Palmitoyl Protein Thioesterase-1) inhibitor, has been granted orphan drug designation (ODD) by the US Food and Drug Administration (FDA)…

February 3, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 21 Nov 2024

Eight areas where gene therapy shines

…Administration (FDA) in 2023. Pfizer is also advancing giroctocogene fitelparvovec, a candidate for the same indication, and recently reported positive phase 3 data. Gene therapy for neurological disorders Neurological disorders…

November 21, 2024 - 12 minutesmins - By Jules Adam

News and Trends 14 Jun 2016

British Biotech startup shows 50% improvement in Atopic Dermatitis

Ziarco has received positive results from a Phase II trial with its leading candidate, which has shown to improve symptoms of atopic dermatitis by 50%, giving it the potential to…

June 14, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 19 Sep 2022

Cyxone receives approval for phase 2b rheumatoid arthritis study

…and multiple sclerosis. Rabeximod is a phase 2 candidate drug being evaluated for the management of rheumatoid arthritis. T20K is a phase 1 candidate drug for treatment of multiple sclerosis….

September 19, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 4 Dec 2017

Israeli Biotech Gets $30M Backing for its Immune Modulators for Severe Infections

Atox Bio develops immune modulators to save patients with severe infections. An oversubscribed Series F financing will support its lead candidate through a Phase II trial. Atox Bio, which has…

December 4, 2017 - 2 minutesmins - By Alex Dale

News and Trends 20 Jul 2017

Sanofi Offers up to €2.4Bn to Belgian Biotech to Develop Nanobodies

…portfolio and the option to gain rights for additional targets, up to a total of eight nanobody candidates. If Sanofi opts in for all eight candidates and they reach commercialization,…

July 20, 2017 - 1 minutemin - By Clara Rodríguez Fernández

Interview 17 Jul 2017

Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares

…of GPCRs are activated by hormones,” said Marshall, “and endocrine diseases are an example of smaller indications where we can more easily take candidates through all the way to the…

July 17, 2017 - 6 minutesmins - By Evelyn Warner

News and Trends 4 Apr 2023

iNtRON looks to control colorectal cancer through microbiome

iNtRON Biotechnology has announced that it has demonstrated the effectiveness of P18-BE3CRC using a cancer organoid model. P18-BE3CRC is a drug candidate from iNtRON Biotechnology’s PHAGERIA platform technology, which is…

April 4, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

5 hearing loss biotech companies you should know about

Can AI cure Alzheimer’s disease?

Hypoparathyroidism: rare endocrine disorder garners attention from biopharma in 2024

5 cell therapy companies you should know about

Genoscience Pharma receives orphan drug designation for hepatocellular carcinoma drug

Eight areas where gene therapy shines

British Biotech startup shows 50% improvement in Atopic Dermatitis

Cyxone receives approval for phase 2b rheumatoid arthritis study

Israeli Biotech Gets $30M Backing for its Immune Modulators for Severe Infections

Sanofi Offers up to €2.4Bn to Belgian Biotech to Develop Nanobodies

Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares

iNtRON looks to control colorectal cancer through microbiome

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!